Raymed Labs has informed that the Meeting of the Board of Directors of the Company will be held on February 10, 2017, to consider and approve the Unaudited Standalone Financial Results for the quarter and period ended on December 31, 2016, and Limited Review Report for the quarter and period ended December 31, 2016. Pursuant to the code of conduct for prevention of insider trading of the company, the trading window for all designated employees & directors will remain closed from January 28, 2017 to February 12, 2017 which is till 48 hours after results are made public on February 10, 2017.
The above information is a part of company’s filings submitted to BSE.
